First Pacific Co Ltd (142) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
First Pacific Co Ltd (First Pacific) is an investment management and holding company with major interests in consumer food products, infrastructure, natural resources, and telecommunications. The company offers consumer branded products such as dairy, snack foods, noodles, food seasonings, foods, and beverages, nutrition and special. It is also involved in the distribution and supply of electricity, operation of toll roads, hospital groups, and water distribution. First Pacific markets its products under the Indomilk, Tiga Sapi, Milkuat, Kremer, Cap Enaak and Indoeskrim brand names. The company has presence across Singapore, Indonesia, and Philippines. First Pacific is headquartered in Hong Kong.
First Pacific Co Ltd Key Recent Developments
May 14, 2026: PLDT Reports 3% Rise in Gross Service Revenues to ?54.9 B in Q1 2026
May 04, 2026: Philex Mining Reports Q1 2026 Financial Results as Silangan Project Enters Process Plant Commissioning
Mar 30, 2026: First Pacific Announces 2025 Full-Year Audited Results
Nov 11, 2025: PLDT Reports 3% Growth in Consolidated Gross Service Revenues to ?158.9 Billion in First Nine Months of 2025
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
CK Life Sciences Int'l (Holdings) Inc - Key Facts
CK Life Sciences Int'l (Holdings) Inc - Key Employees
CK Life Sciences Int'l (Holdings) Inc - Key Employee Biographies
CK Life Sciences Int'l (Holdings) Inc - Major Products and Services
CK Life Sciences Int'l (Holdings) Inc - History
CK Life Sciences Int'l (Holdings) Inc - Company Statement
CK Life Sciences Int'l (Holdings) Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
CK Life Sciences Int'l (Holdings) Inc - Business Description
Business Segment: Agriculture-Related
Overview
Performance
Key Stats
Business Segment: Nutraceutical
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals & Diagnostics R&D
Overview
Performance
Business Segment: Unallocated
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: North America
Performance
R&D Overview
CK Life Sciences Int'l (Holdings) Inc - Corporate Strategy
CK Life Sciences Int'l (Holdings) Inc - SWOT Analysis
SWOT Analysis - Overview
CK Life Sciences Int'l (Holdings) Inc - Strengths
CK Life Sciences Int'l (Holdings) Inc - Weaknesses
CK Life Sciences Int'l (Holdings) Inc - Opportunities
CK Life Sciences Int'l (Holdings) Inc - Threats
CK Life Sciences Int'l (Holdings) Inc - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
CK Life Sciences Int'l (Holdings) Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
May 18, 2026: CK Life Sciences Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer
Mar 31, 2026: CK Life Sciences’ Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting
Mar 10, 2026: CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development
Aug 12, 2025: CK Life Sciences : 2025 First Half Results - An Increase in R&D Investments
Apr 22, 2025: CK Life Sciences Investigational Cancer Vaccines Deliver Promising Results - New Preclinical Study Data to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Apr 22, 2025: Business Update on Preclinical Studies of Cancer Vaccines And the Progress of Research Collaboration to Develop An AI-Empowered Cancer Vaccine Platform
Section 6 - Appendix
Methodology
Ratio Definitions
About the Analyst
Contact the Publisher
Disclaimer
List of Tables
CK Life Sciences Int'l (Holdings) Inc, Key Facts
CK Life Sciences Int'l (Holdings) Inc, Key Employees
CK Life Sciences Int'l (Holdings) Inc, Key Employee Biographies
CK Life Sciences Int'l (Holdings) Inc, Major Products and Services
CK Life Sciences Int'l (Holdings) Inc, History
CK Life Sciences Int'l (Holdings) Inc, Subsidiaries
CK Life Sciences Int'l (Holdings) Inc, Key Competitors
CK Life Sciences Int'l (Holdings) Inc, Ratios based on current share price
CK Life Sciences Int'l (Holdings) Inc, Annual Ratios
CK Life Sciences Int'l (Holdings) Inc, Interim Ratios
CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
CK Life Sciences Int'l (Holdings) Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
CK Life Sciences Int'l (Holdings) Inc, Performance Chart (2021 - 2025)
CK Life Sciences Int'l (Holdings) Inc, Ratio Charts
CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net